Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 23/02/21

Trade details

Type: Insider sale
Amount: $544,864.86
Shares · price: 11,061 sh · $49.26 a share
Held after: 633,666 sh
Stock: Halozyme Therapeutics HALO
Person: Helen TorleyPresident and CEO
Trade date: 23/02/16
Filed: 23/02/21
Days to filing: 5 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/17~23/03/18

Helen Torley's recent trades

Helen TorleyPresident and CEO
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$23.7M
240,000 sh
$23.7M
Filed 08/17
Traded 08/17
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$425.1K
6,100 sh
$425.1K
Filed 06/03
Traded 06/03
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01

Helen Torley, CEO — sold $544.9K of Halozyme Therapeutics HALO · 1.7% of holdings | Whalegun